Combination of Cisplatin and Melatonin on the Inhibition of Cisplatin Resistance in SKOV3 Cells

Published: 3 January 2023| Version 1 | DOI: 10.17632/ftdpsfwrtv.1
Contributor:
Cut Adeya Adella

Description

This data shows about outcome of flowcytometry for the variables (CTR-1, Pgp, E-Cadherin, GSH, ERCC1, and Annexin V for all the study groups including the combination of melatonin and cisplatin groups

Files

Steps to reproduce

We used experiment laboratory design using combination of cisplatin and melatonin in cisplatin-resistant ovarian cancer cell was conducted using SKOV3. Cell was cultured and harvested, MTS assay was used for cell viability and flowcytometry for the study.

Institutions

Universitas Sumatera Utara

Categories

Cancer Treatment, Gynecological Oncology

License